Picture of Aquestive Therapeutics logo

AQST Aquestive Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareAdventurousMid CapMomentum Trap

Aquestive Therapeutics Inc reports results for the quarter ended in December - Earnings Summary

* Aquestive Therapeutics Inc  AQST.OQ  reported a quarterly
adjusted loss of 11 cents​​ per share for the quarter ended in
December, higher than the same quarter last year, when the
company reported EPS of -23 cents.  The mean expectation of
six analysts for the quarter was for a loss of 8 cents per
share. Wall Street expected results to range from -11 cents
to -4 cents per share.
    * Revenue rose 23.6% to $13.21 million from a year ago;
analysts
expected $11.63 million. 
    * Aquestive Therapeutics Inc's reported EPS for the quarter
was a
loss of 12 cents​.
    * The company reported a quarterly loss of $8.11 million.
    * Aquestive Therapeutics Inc shares had risen by 106.9% this
quarter.

FORECAST CHANGES
    * The mean earnings estimate of analysts was unchanged in
the last
three months.​ 
    * In the last 30 days, there have been no earnings estimate
revisions by analysts covering the company.

RECOMMENDATIONS
    * The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 6 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
    * The average consensus recommendation for the
pharmaceuticals
peer group is also "buy"

Wall Street's median 12-month price target for Aquestive
Therapeutics Inc is $6.50 
This summary was machine generated from LSEG data March 6 at
12:13 a.m. UTC. ​All figures in US dollars unless otherwise
stated. (For questions concerning the data in this report,
contact Estimates.Support@lseg.com. For any other questions or
feedback, contact RefinitivNewsSupport@thomsonreuters.com) QUARTER ENDING    ESTIMATE       ACTUAL         BEAT, MET,
                                                 MISSED
 Dec. 31 2023      -0.08          -0.11          Missed
 Sep. 30 2023      -0.11          -0.03          Beat
 Jun. 30 2023      -0.12          -0.10          Beat
 Mar. 31 2023      -0.19          -0.12          Beat

Recent news on Aquestive Therapeutics

See all news